MedTrace Logo

An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)

NCT02408224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2018-06-25

No results posted yet for this study

Summary

The TREASURE observational study is designed to address the need to understand the usage pattern of Ticagrelor in real life scenario in large number of ACS (Acute Coronary Syndrome) patients in India. The aim of this national study is to understand the usage pattern (including the duration of treatment) of Ticagrelor in various ACS patient population undergoing PCI (Percutaneous Coronary Intervention), CABG (Coronary Artery Bypass Graft) or medical management in a real-life setting in India.

Conditions

  • Acute Coronary Syndrome

Sponsors & Collaborators

Principal Investigators

  • JP S Sawhney, MBBS, MD, DM · Sir Ganga Ram Hospital, Delhi

  • Bhavesh P Kotak, MBBS MD · AstraZeneca Pharma India Ltd

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-27
Primary Completion
2017-06-24
Completion
2017-06-24

Countries

  • India

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02408224 on ClinicalTrials.gov